13G Filing: Opaleye Management and Tonix Pharmaceuticals Holding Corp. (TNXP)

Page 2 of 8 – SEC Filing

 

CUSIP
No.
890260409

 

     NAMES
OF REPORTING PERSONS
     Opaleye
Management Inc.
   
1

   I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

   20-5648796

   
     CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
     (a)   [  ]
2    (b)   [  ]
     SEC
USE ONLY
   
3  
     CITIZENSHIP
OR PLACE OF ORGANIZATION
   
4    Massachusetts
NUMBER
OF SHARES

BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH:
     SOLE
VOTING POWER
   
5    0
     SHARED
VOTING POWER
   
6    413,593
     SOLE
DISPOSITIVE POWER
   
7    0
     SHARED
DISPOSITIVE POWER
   
8    413,593
     AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
9    413,593
     CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
10    [  ]
     PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
11    5.52%
(based on 7,486,026 common shares issued and outstanding as of April 13, 2017)
     TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS)
   
12    CO

 

Follow Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)